Full Press Release Details
THIS ANNOUNCEMENT IS FOR INFORMATIONAL
PURPOSES ONLY AND DOES NOT CONSTITUTE OR FORM PART OF ANY OFFER OR INVITATION TO SELL, OR ANY SOLICITATION OF AN OFFER TO PURCHASE, ANY SECURITIES OF PHILIPS.
Philips launches offering of Green and Sustainability Innovation Notes and a Series of Liability Management Transactions
Amsterdam, the Netherlands Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the intention to
issue one or more series of notes (the Notes ) under its European Medium Term Note (EMTN) program (the EMTN Offering ), as well as a series of liability management transactions, which are expected to extend the company s
debt maturity profile.
With these transactions, Philips aims to leverage current financial market conditions to further optimize its debt maturity
profile and liabilities. Once completed these transactions are expected to have a neutral impact on the amount of debt outstanding.
the Notes will be used for Eligible Projects in accordance with Philips Green and Sustainability Innovation Bond Framework. Pending the full allocation of the net proceeds of the Notes, Philips intends to optimize its short-term treasury liquidity
profile by applying such net proceeds towards the following liability management transactions, all of which are subject to the successful completion of the EMTN Offering:
Any decision by Philips to redeem outstanding bonds in the Euro Make-Whole Redemptions, or to complete the
Early Forward Settlement, will depend on various factors at that time.
For further information, please contact:
Philips Global Press Office
Tel.: +31 6 1521 3446
E-mail: ben.zwirs@philips.com
Philips Investor Relations
Tel.: +31 20 5977055
E-mail: derya.guzel@philips.com
Royal Philips (NYSE: PHG, AEX: PHIA)
is a leading health technology company focused on improving people s health and well-being, and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips
leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics,
as well as in consumer health and home care. Philips generated 2021 sales of EUR 17.2 billion and employs approximately 78,000 employees with sales and services in more than 100 countries. News about Philips can be found at
Forward-looking statements
This release contains certain forward-looking statements with respect to the financial condition, results of operations and business of Philips and certain of
the plans and objectives of Philips with respect to these items. Examples of forward-looking statements include statements made about the EMTN Offering, the USD Tender Offer, the Euro Tender Offer, the Euro Make-Whole Redemption and the Early
Forward Settlement. By their nature, these statements involve risk and uncertainty because they relate to future events and circumstances and there are many factors that could cause actual results and developments to differ materially from those
expressed or implied by these statements.
Important Information
This announcement is for informational purposes only and does not constitute or form part of any offer or invitation to sell, or any solicitation of an offer
to purchase, any securities of Philips. The securities offered in the EMTN Offering have not been and will not be registered under the Securities Act of 1933, as amended (the Securities Act ), and may not be offered or sold in the United
States absent registration or an applicable exemption from registration
requirements. Neither the EMTN Offering nor the Euro Tender Offer is being made and will not be made directly or indirectly in or into, or by use of the mails of, or by any means or
instrumentality (including, without limitation, facsimile transmission, telex, telephone, email and other forms of electronic transmission) of interstate or foreign commerce of, or any facility of a national securities exchange of, or to owners of
the subject securities who are located or resident in the United States or to U.S. Persons as defined in Regulation S of the Securities Act.
United Kingdom, this announcement is being distributed to, and is directed at, only (a) persons who have professional experience in matters relating to investments who fall within the definition of investment professionals in
Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, as amended (the Order ); or (b) high net worth companies, and other persons to whom it may otherwise lawfully be communicated, falling
within Article 49(2)(a) to (d) of the Order (all such persons together being referred to as relevant persons ). The Notes are available only to, and any invitation, offer or agreement to subscribe, purchase or otherwise acquire
such Notes will be available only to or will be engaged in only with, relevant persons. Any person who is not a relevant person should not act or rely on this announcement or any of its contents.
Manufacturer target market (MIFID II and UK MiFIR product governance) is eligible counterparties and professional clients only (all distribution channels). No
PRIIPs or UK PRIIPs key information document (KID) has been prepared as not available to retail in EEA or UK.